Flow cytometer reagents market information: by type (calibration and validation reagents, specificity reagents, supporting reagents, secondary reagents, isotype controls, buffers, others), by applications (diagnostics, drug discovery, others) by end users (pharmaceutical and biotechnology industry, academic and research centers, diagnostic centers, others) - Global forecast till 2027
ID: MRFR/LS/2805-HCR | February 2021 | Region: Global | 90 pages
Market Synopsis of Global Flow cytometer reagents Market
Market scenario
Flow cytometer reagents are used for calibrating, maintaining, validating and conducting or supporting the experiments. Thus, they are essential for the normal and satisfactory working of the instrument. Calibration reagents are used for validating that the instrument records the values consistent with the actual or real concentration or number of cells. These are proprietary and contain particle concentration in a narrow range. The buffers are used to maintain the pH of the solutions used in flow cytometry. Specificity reagents are used to bind selectively to the sample particles so as to ease detectability.
The market for flow cytometer reagents is rising fast due to increasing use of flow cytometry in pharmaceutical and biotechnological industry, launch of new reagents for specific applications like diagnostics & drug discovery, development of user-friendly & software, growing prevalence of infectious diseases etc. The market restraints are the high cost of the flow cytometer reagents because of the proprietary nature of most reagents and the lack of transparency in the market.
A close look at the market reveals that product development is the most attractive strategy which has been exploited by many market players. The high profit margin and returns on investment on the flow cytometer reagents has led to the growth of the market with many large firms entering the market. The growing adoption of flow cytometry techniques in research activities especially drug development has led to growth of the market for flow cytometer reagents. Another important driver has been the increasing adaptation and automation of flow cytometer in diagnostics especially infectious diseases.
The global flow cytometer reagents market is expected to reach US$ 8.88 billion by 2023, and the market is projected to grow at a CAGR of ~ 12.0 % during the forecast period 2017-2023.
Research Methodology:
Sources: Mayo Clinic, MRFR Analysis
Intended Audience
- Global flow cytometer reagents manufacturers & suppliers
- Research and development (R&D) companies
- Hospitals and clinics
- Academic institutes and universities
Figure 1 Global flow cytometer reagents market by end users, 2016 (% market share)
Segments:
The global flow cytometer reagents market has been segmented on the basis of types, applications, and end users.
Based on types, the market has been segmented as the calibration and validation reagents, specificity reagents, supporting reagents, secondary reagents, isotype controls, buffers and others.
Based on the applications, the market has been segmented into diagnostics, drug discovery and others.
Based on the end users, the market has been segmented as pharmaceutical and biotechnology industry, academic and research centers, diagnostic centers and others.
Regional analysis:
The Americas account for the significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global flow cytometer reagents market. Also, the concentration of the major research companies and biotechnology sector in the developed countries of this region is adding fuel to the market.
Europe is the second largest market in the world due to high industrial and research base.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing industrial sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Key Players in the Global Flow cytometer reagents Market
Some of key players profiled in the report are Biocompare, Bio-Rad Laboratories, Inc., Miltenyi Biotec, BioLegend, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, ImmunoReagents, Inc., Thermo Fisher Scientific and others.
The report for Global Flow cytometer reagents market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Frequently Asked Questions (FAQ) :
The Valuation Would be USD 8.88 Billion.
The Flow Cytometer Reagents Market Has Been Predicted to Grow with a CAGR of 12% During the Forecast Period of 2017-2023.
The Types Are Specificity Reagents, Calibration & Validation Reagents, Secondary Reagents, Isotype Controls, Supporting Reagents, Buffers, And Others.
The End Users Are Diagnostic Centers, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, And Others.
The Americas Would Lead the Market Growth.
1. Introduction
1.1 Definition
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market factor analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power of Suppliers
4.3 Bargaining Power of Buyers
4.4 Threat of New Entrants
4.5 Threat of Substitutes
4.6 Intensity of Rivalry
5. Global Flow Cytometer Reagents Market, by Types
5.1 Calibration And Validation Reagents
5.2 Specificity Reagents
5.3 Buffers
5.4 Supporting Reagents
5.5 Secondary Reagents
5.6 Isotype Controls
5.7 Others
6. Global Flow Cytometer Reagents Market, by Applications
6.1 Diagnostics
6.3 Drug Discovery
6.4 Others
7. Global Ureteral Obstruction Market, by End Users
7.1 Pharmaceutical And Biotechnology Industry
7.2 Academic and Research Centres
7.3 Diagnostic Centers
7.4 Others
8. Global Flow Cytometer Reagents Market, by Region
8.1 North America
8.1.1 Introduction
8.2 Europe
8.2.1 Introduction
8.3 Asia Pacific
8.3.1 Introduction
8.4 Middle East & Africa
8.4.1 Introduction
9. Competitive landscape
9.1 Major Strategies Adopted by Market Players
9.1.1 Strategic Partnership
9.1.2 Merger & Acquisition
10. Company profile
10.1 Biocompare
10.1.1 Overview
10.1.2 Product Overview
10.1.3 Financials
10.1.4 Key Developments
10.2 Bio-Rad Laboratories, Inc.
10.2.1 Overview
10.2.2 Product Overview
10.2.3 Financials
10.2.4 Key Developments
10.3 Miltenyi Biotec
10.3.1 Overview
10.3.2 Product Overview
10.3.3 Financials
10.3.4 Key Development
10.4 BioLegend, Inc.
10.4.1 Overview
10.4.2 Product Overview
10.4.3 Financials
10.4.4 Key Developments
10.5 Becton, Dickinson and Company
10.5.1 Overview
10.5.2 Product Overview
10.5.3 Financials
10.5.4 Key Developments
10.6 Beckman Coulter, Inc.
10.6.1 Overview
10.6.2 Product Overview
10.6.3 Financials
10.6.4 Key Developments
10.7 Merck KGaA
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.8 ImmunoReagents, Inc.
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.9 Thermo Fisher Scientific
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.10 Others
11. Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of The Market
11.2 Key Companies to Watch
11.3 Prediction of Flow Cytometer Reagents Industry
12. Appendix
